The revision of bioequivalence guidelines and the enhancement of good manufacturing practice (GMP) requirements facilitate the rational development and manufacturing control of generic formulations.
In countries with less mature healthcare systems, both physicians and pharmacists were highly concerned about the manufacturing sources of generic drugs and the companies' trustworthiness [ 22, 24, 25, 29, 30, 32, 33].
This is perhaps due to the importance of setting a reasonable criterion on the part of a regulatory agency such as the FDA in the US in regulating the manufacturing of drugs (especially generic drugs).
While both companies have operations in the United States, the Swiss drug maker has a larger share of generic drug manufacturing overseas, particularly in Eastern Europe.
While both companies have operations in the United States, Actavis has a larger share of generic drug manufacturing overseas, particularly in Eastern Europe.
The loss of patent protection and increased generic manufacturing of glyphosate has placed downward pressure on prices since 2000 [30, 45, 46].
At the end of the first decade, the companies must agree to allow generic manufacturing of the drug [ 42].
"With cheap manufacturing, including 3D printing, and the idea of generic artificial intelligence, we're not far away," he says.
It has also to encourage domestic manufacturing of good quality and affordable generic drugs and to implement robust policies to ensure domestic market utilisation of these drugs.
